203
EXTON, PA. — Morphotek has opened an $80 million manufacturing plant in Exton, which will begin production operations later this year. The 60,000-square-foot facility will enable the company to make proprietary biologic therapeutic products for use in early-stage clinical trials. Its new product pipeline includes antibodies to treat cancer and autoimmune diseases.